Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: well performed GLP and OECD guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1987
Report date:
1987

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
(This applies even though the guideline was not cited in the report)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-(2,5-dimethoxyphenyl)acetamide
EC Number:
222-423-1
EC Name:
N-(2,5-dimethoxyphenyl)acetamide
Cas Number:
3467-59-2
Molecular formula:
C10H13NO3
IUPAC Name:
N-(2,5-dimethoxyphenyl)acetamide
Details on test material:
- Name of test material (as cited in study report): 2-Acetamino-1.4-dimethoxybenzol

Method

Species / strain
Species / strain / cell type:
other: S. typhimurium TA 1535, TA 1537, TA 1538, TA 98, TA 100 and E. coli WP2uvrA
Metabolic activation:
with and without
Metabolic activation system:
Aroclor 1254 induced rat liver S9 mix
Test concentrations with justification for top dose:
Experiment I:
all strains 0, 4, 20, 100, 500, 2500, 10000 µg/plate with and without metabolic activation
Experiment II:
all strains 0, 4, 20, 100, 500, 2500, 5000 µg/plate with and without metabolic activation
Vehicle / solvent:
DMSO
Controls
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 9-Aminoacridine, Sodium azide, 2-Nitrofluorene, N-Methyl-N-nltro-N-nitrosoguanidine, 2-Aminoanthracen, Benzo(a)pyrene
Evaluation criteria:
Positive: significant increase in the number of revertant colonies, or a dose response relationship

Results and discussion

Test results
Species / strain:
other: S. typhimurium TA 1535, TA 1537, TA 1538, TA 98, TA 100 and E. coli WP2uvrA
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
slight toxicity at 10000µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

It is concluded that 2-Acetamino-1.4-dimethoxybenzol is not mutagenic in this Ames test.
Executive summary:

2-Acetamino-1.4-dimethoxybenzol was tested for mutagenicity with tester strains TA l00, TA 1535, TA 1537, TA 1538, TA 98 of Salmonella typhimurium and Escherichia coli WP2uvrA according to OECD guideline 471.

 

The mutagenicity studies were conducted in the absence and in the presence of a metabolizing system derived from rat liver homogenate. A dose range of 6 different doses from 4 µg/plate to 10000/5000 µg/plate was used in experiment 1 and 2.

Control plates without mutagen showed that the number of spontaneous revertant colonies was similar to that described in the literature. All the positive control compounds gave the expected increase in the number of revertant colonies.

 

Toxicity: The test compound proved to be not toxic to the bacterial strains up to 5000 µg/plate. 10000/5000µg/plate was chosen as top dose level for the mutagenicity study in experiment 1 and 2.

 

Mutagenicity: In the absence of the metabolic activation system the test compound did not show a dose dependent increase in the number of revertants in any of the bacterial strains. Also in the presence of a metabolic activation system, treatment of the cells with 2-Acetamino-1.4-dimethoxybenzol did not result in relevant increases In the number of revertant colonies.

 

Summarizing, it can be stated that 2-Acetamino-1.4-dimethoxybenzol is not mutagenic in these bacterial test systems either with or without exogenous metabolic activation at the dose levels investigated.